Advertisement

BioMetals

, Volume 23, Issue 2, pp 181–184 | Cite as

Can iron be teratogenic?

  • E. D. WeinbergEmail author
Article

Abstract

Several kinds of evidence indicate that elevated iron during the 3–8 week embryonic (organogenesis) period of human gestation may be teratogenic. (1) In the embryonic period, the natural maternal absorption of food iron is 30% below the estimated daily iron loss. (2) As compared with maternal serum, embryonic fetal coelomic fluid contains only one-fourth as much iron but nearly six times the quantity of the iron withholding protein, ferritin. (3) In the embryonic period, intraplacental oxygen pressure is 2–3 times lower than in the subsequent fetal growth period. (4) Iron is a strong inducer of emesis which peaks in the embryonic period. (5) In a murine gestation model, iron was neurotoxic at a sharp peak of 8–9 days. Thus it would be prudent, in human pregnancy, to delay any needed iron supplementation until the embryonic period has been completed.

Keywords

Embryonic period Iron Pregnancy Teratogen 

References

  1. Agarwal A, Gupta S, Sikka S (2006) Role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gyecol 18:325–332CrossRefGoogle Scholar
  2. Arosio P, Ingrassia R, Cavadini P (2009) Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790:589–599PubMedGoogle Scholar
  3. Barrett JF, Whittaker PC, Williams JG, Lind T (1994) Absorption of non-haem iron from food during normal pregnancy. Br Med J 309:79–82Google Scholar
  4. Casenueva E, Viteri FE (2003) Iron and oxidative stress in pregnancy. J Nutr 133:1700S–1708SGoogle Scholar
  5. Connor JR, Ghio AJ (2009) Th impact of host iron homeostasis on disease. Biochim Biophys Acta 1790:581–582PubMedGoogle Scholar
  6. Dickanovic N, Garcia-Bournissen F, Koren G (2008) Medications for restless legs syndrome in pregnancy. J Obstet Gynaecol Can 30:505–507Google Scholar
  7. Dunkel VC, San RH, Selfried HE, Whittaker F (1999) Genotoxicity of iron compounds in Salmonella typhimurium and L5178Y mouse lymphoma cells. Environ Mol Mutagen 33:28–41CrossRefPubMedGoogle Scholar
  8. Eby JE, Sato H, Sirbasku DA (1993) Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: role of Fe(II) chelation. J Cell Physiol 156:588–600CrossRefPubMedGoogle Scholar
  9. Forhoui NG, Harding AH, Allison M, Sandu MS, Welch A, Luben R, Bingham S, Khaw KT, Warcham NJ (2007) Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 50:949–956CrossRefGoogle Scholar
  10. Gadsby R, Barnie-Adshead AM, Jagger C (1993) A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 43:245–248PubMedGoogle Scholar
  11. Gilbert S (2008) Medical implications of developmental biology. In: Gilbert SF (ed) Developmentl biology, 8th edn. Sinnauer Associates, Sunderland, pp 655–692Google Scholar
  12. Gill SK, Nguyn P, Koren G (2009) Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions. J Obstet Gynaecol 29:594–598CrossRefPubMedGoogle Scholar
  13. Gulbis B, Jauniaux E, Decuyper J, Thiry P, Jurkovic D, Campbell S (1994) Distribution of iron and iron-binding proteins in first trimester pregnancies. Obstet Gynecol 84:289–293PubMedGoogle Scholar
  14. Jauniaux E, Poston L, Burton GJ (2006) Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12:747–755CrossRefPubMedGoogle Scholar
  15. Jones RE, Lopez KH (2006) Human reproductive biology, 3rd edn, chap 10. Academic press, Oxford, pp 253–296Google Scholar
  16. Kuchta B (1982) Experiments and ultrastructural investigations on the mouse embryo during early teratogen-sensitive stages. Acta Anat (Basel) 113:218–225CrossRefGoogle Scholar
  17. Larson WJ (2001) Human embryology. Churchill Livingstone, EdinburghGoogle Scholar
  18. Mainous AG III, Gill JM, Carek PJ (2004) Elevated serum transferrin saturation and mortality. Ann Fam Med 2:133–138CrossRefPubMedGoogle Scholar
  19. McCord JM (1996) Effects of positive iron status at a cellular level. Nutr Rev 54:85–88PubMedCrossRefGoogle Scholar
  20. Moore KL, Persaud TNN (1993) Before we are borne: essentials of embryology and birth defects. W.B. Saunders, PhiladelphiaGoogle Scholar
  21. Schulz KJ, Chrstian P, Ruczinski I, Ray AL, Nath A, Wu LS-F, Semba RD (2008) Hepcidin and iron status among pregnant women in Bangladesh. Asia Pac J Clin Nutr 17:451–456Google Scholar
  22. Svanberg B (1975) Iron absorption in early pregnancy—a study of the absorption of non-haem iron and ferrous iron in early pregnancy. Acta Obstet Gynecol Scand Suppl 48:69–85CrossRefPubMedGoogle Scholar
  23. Weinberg ED (2008) Role of iron in osteoporosis. Ped Endocrin Revs 6(Suppl 1):81–85Google Scholar
  24. Weinberg ED (2009a) Iron toxicity: new conditions continue to emerge. Oxid Med Cell Longev 2:107–109PubMedGoogle Scholar
  25. Weinberg ED (2009b) Are iron supplements appropriate for iron replete pregnant women? Med Hypoth 73:714–715CrossRefGoogle Scholar
  26. Weinberg ED (2009c) First trimester curtailment of iron absorption: innate suppression of a teratogen? Med Hypoth 73 (in press)Google Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  1. 1.Department of Biology & Program in Medical SciencesIndiana UniversityBloomingtonUSA

Personalised recommendations